Thrombocytopenia

dc.contributor.authorAcunas, B
dc.contributor.authorÇeltik, C
dc.contributor.authorVatansever, Ü
dc.contributor.authorKarasalihoglu, S
dc.date.accessioned2024-06-12T11:17:22Z
dc.date.available2024-06-12T11:17:22Z
dc.date.issued2000
dc.departmentTrakya Üniversitesien_US
dc.description.abstractBackground: The conventional therapeutic approach in polycythemic newborn infants is to apply partial exchange transfusion (PET) when hematocrit value exceeds 70% or when the infant develops symptoms with the exception of plethora. Methods: In order to investigate the possibility of using platelet count as a simple criterion implying the PET requirement, we retrospectively reviewed polycythemic newborn infants with respect to the relationship between thrombocytopenia and severity of symptoms, and the association of platelet count and the PET performance. Thrombocytopenia has been defined as a platelet count < 150 000/mu L. Results: We studied 18 polycythemic infants with thrombocytopenia (group 1, 35%) and 34 without it (group 2, 65%). Perinatal asphyxia, gestational toxemia and intrauterine growth retardation, which are the three common causative factors leading to polycythemia, were not significantly different in the two groups. No correlation existed between platelet counts and hematocrit values within each group, but there was a very significant difference between the two groups in terms of severity of clinical findings (P < 0001); no difference in terms of moderate findings and moderately significant difference with respect to mild symptoms and asymptomatic situation (P < 0.05). Partial exchange transfusion was performed in all patients in group 1, while only 12 infants in group 2 (32%) received transfusion and the difference was statistically significant (P < 0.05). A significant rise in platelet counts has been achieved only in group 1, while hematocrit values decreased significantly in both groups following PET. Conclusions: This study emphasizes the relationship between thrombocytopenia and the severity of clinical findings and PET performance rate in polycythaemic newborn infants, implying that thrombocytopenia is a possible marker of hyperviscosity, the results of which warrant further investigation.en_US
dc.identifier.doi10.1046/j.1442-200x.2000.01244.x
dc.identifier.endpage347en_US
dc.identifier.issn1328-8067
dc.identifier.issue4en_US
dc.identifier.pmid10986862en_US
dc.identifier.startpage343en_US
dc.identifier.urihttps://doi.org/10.1046/j.1442-200x.2000.01244.x
dc.identifier.urihttps://hdl.handle.net/20.500.14551/24685
dc.identifier.volume42en_US
dc.identifier.wosWOS:000089105400003en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherBlackwell Science Asiaen_US
dc.relation.ispartofPediatrics Internationalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectWords Newbornen_US
dc.subjectPartial Exchange Transfusionen_US
dc.subjectPolycythemiaen_US
dc.subjectThrombocytopeniaen_US
dc.subjectNeonatal Polycythemiaen_US
dc.subjectHyperviscosityen_US
dc.subjectBlooden_US
dc.titleThrombocytopeniaen_US
dc.typeArticleen_US

Dosyalar